As of September 17, 2020, there are over 29.9 million COVID-19 cases and 941,000 deaths worldwide. The United States leads the count with over 6.65 million cases and 197,000 deaths. The influential model from the Institute for Health Metrics and Evaluation projects there could be approximately 415,000 COVID-19 deaths by January 1, 2021 in the… Read more about Flu Season & the Pandemic: Twindemic or a Manageable Crisis?
On Sunday, August 23, the US Federal Food and Drug Administration (FDA) announced an Emergency Use Authorization (EUA) for convalescent plasma as a treatment for hospitalized COVID-19 patients citing “known and potential benefits of the product outweigh the known and potential risks of the product.” The EUA would effectively enable physicians to treat COVID-19 patients… Read more about COVID-19 Update: Convalescent Plasma
Vaccine development for COVID-19 is topic number one, and our collective hope for going back to “normal” dangle on that needle. The global race to market includes pharma’s heavy hitters like Pfizer, Johnson & Johnson, AstraZeneca, and Moderna, a Cambridge, Massachusetts-based company that displayed hopeful results in Phase-1 trials and just this week received another… Read more about COVID-19 Update: The Race for a Vaccine
As the US topped a whopping 2.8 million cases and a death count of 130,000 last week, cities and towns across the nation canceled July 4th firework displays and large public gatherings in an effort to prevent further spread of COVID-19. The fervor for holiday travel was scaled down this past weekend compared to prior… Read more about COVID-19 Update: The Disparity Between the US and the EU COVID-19 Experience
When movies are made about the COVID-19 pandemic, the city of New York will have a starring role. Once the epicenter of the virus outbreak, the densely populated city endured months of significantly high rates of confirmed infections and reported deaths. As cases began to steadily decrease in the month of May, Governor Cuomo’s daily… Read more about COVID-19 Update: What is the New Normal for Businesses?
Improved data collection and relaxed social distancing will likely lead to an increase in both the perceived and actual spread of COVID-19 Part I: The Numbers Since the beginning of the COVID-19 outbreak, data has been scrutinized for accuracy. Are officials capable of reporting correct numbers? How do we reconcile the lack of resources to… Read more about Why COVID-19 Infections May Resurge
This page was last updated on May 5, 2020. Overview: The United States is experiencing sustained human-to-human transmission of the novel COVID-19 virus, first discovered in Wuhan, China in December 2019. Since then, every state in the US has confirmed cases, and new cases are emerging every day. Susceptibility to the virus sub-type may also… Read more about COVID-19 FACT SHEET WITH PHYSICIAN-RECOMMENDED PREVENTATIVE MEASURES
Serological testing, also known as antibody testing, is a critical element of discussion when determining how and when the country will reopen. The process requires a blood sample to detect the presence of neutralizing antibodies (IgM, IgG) against a microorganism. Serological antibody tests are unlike polymerase chain reaction (PCR) diagnostic tests as the latter specifically… Read more about Coronavirus Update: Serological Testing
Reopening the Country Just 6 weeks ago, the US had 100 confirmed cases of COVID-19 and 6 deaths – all in Washington state. Today, the country is a vastly different place. There are 560,433+ confirmed cases in all 50 states and in all US-held territories, and 22,115+ COVID-19 related deaths and the US leads the… Read more about Coronavirus Update: Reopening the Country
COVID-19 Modeling & Projections One of the only constants of the COVID-19 pandemic is how often data and projections are changing. This is frustrating for our society, as there is a collective overwhelming desire to know when the US will hit its peak of cases, and when life can resume normalcy, and those timelines seem… Read more about Coronavirus Update: COVID-19 Modeling & General-Use Face Masks
